HOUSTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Diag-Nose.io, a cutting-edge biotech company pioneering precision medicine for respiratory disorders, has announced...
DiagNose.io
BETHLEHEM, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- A groundbreaking precision medicine system developed by biotech trailblazer Diag-Nose.io hopes to...
Breakthrough Victoria has invested $800,000 in Diag-Nose.io Medical (DNM), a Melbourne-based innovator in respiratory healthcare, to enhance clinical management and...